On July 14, 2015, the NRC issued a Notice of Violation to Monongalia General Hospital (MGH) for a Severity Level III violation. The violation involved the failure to have two written directives dated and signed by an authorized user before the administration of I-131 sodium iodide as required by 10 CFR 35.40(a). Specifically, on February 8, 2013, and on February 26, 2013, MGH administered I-131 sodium iodide and the two individuals that signed and dated the written directives were not listed as authorized users on its NRC license.